Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Iridium (III) complexes containing N-heterocyclic carbene ligand, synthesis, and their use thereof in cancer treatment

Iridium (III) complexes containing N-heterocyclic carbene ligand, synthesis, and their use thereof in cancer treatment

US Patent 11286271 · Granted Mar 29, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tetradentate ligands, gold(III) complexes, preparation method and use thereof2025
Osteogenic agents and uses thereof2025
Iron catalyzed highly enantioselective cis-dihydroxylation of quinones2025
Platinum (II) Schiff base complexes with increased emission quantum yield for re2024
Platinum (II) Schiff base complexes with increased emission quantum yield for re2024
Methods of iron catalyzed C-H bond amination2024
Spiro-containing platinum(II) emitters with tunable emission energies and synthe2024
Gold porphyrin-PEG conjugates and methods of use2021
Tungsten(VI) complexes for OLED application2021
Platinum (II) emitters for OLED applications2021
Organometallic compound, organic light-emitting device including organometallic 2021
Organometallic compound, organic light-emitting device including organometallic 2021